Healthy volunteers help uncover drug interactions
NCT ID NCT06846684
First seen Nov 19, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This study looked at how a new drug called SB17170 changes the way the body processes another drug, SB_MDZ, in 12 healthy adults aged 19 to 50. Participants took SB17170 and SB_MDZ by mouth in a fixed order, and researchers measured drug levels in the blood. The goal was to understand if SB17170 affects the breakdown of SB_MDZ, which helps guide safe dosing in future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG DRUG INTERACTION (DDI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.